Charles River Laboratories | CRL - Selling And Administration Expenses

Stock Price
169.80
Daily Change
2.06 1.23%
Monthly
2.36%
Yearly
48.09%
Q2 Forecast
166.17

Charles River Laboratories reported $196.14M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cigna USD 3.19B 242M Sep/2025
Concord Medical Services Hldg CNY 140.37M 36.24M Jun/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 383M 28M Dec/2025
Elevance Health USD 10.91B 309M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 283M 27M Dec/2025
Incyte USD 390.41M 61.33M Dec/2025
Intrexon USD 10.31M 41K Jun/2024
IQVIA Holdings USD 468M 46M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
McKesson USD 2.03B 44M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Revvity USD 251.73M 9.82M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
United Therapeutics USD 190.6M 38.6M Dec/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 240.01M 25.78M Dec/2025
West Pharmaceutical Services USD 99.5M 7M Mar/2026